Smart Pills Market: Key Growth Factors and Opportunity Analysis by 2027

The global Smart Pills Market is expected to exhibit a strong 14.2% CAGR over the forecast period from 2022 to 2030, according to the latest research report from Market Research Future (MRFR).

The report presents a detailed analysis of the global Smart Pills Market by providing readers with a comprehensive overview of the market’s historical trajectory. The leading drivers and restraints affecting the global smart pills market are assessed in detail in the report. The historical impact of these drivers and restraints is analysed in context of the current impact of these factors and projections are made for the likely impact of these drivers and restraints over the forecast period. Various components of the global smart pills market are also studied in the report and projections are made for the growth trajectory of each distinct component. The various segments and sub-segments within the global smart pills market are studied in detail in the report. The study also makes a detailed analysis of the major players operating in the global smart pills market and provides a detailed look at the various competitive strategies employed by players in the global smart pills market. Likely future conditions with respect to the competitive landscape of the market are also explained in detail in the report.

Segmentation:

The global megalife pills market is segmented on the basis of application, target area, disease indication, end user, and region.

On the basis of application, the global smart pills market is segmented into capsule endoscopy, drug delivery, patient monitoring, and others. The capsule endoscopy segment has been further divided into small bowel capsule endoscopy, controllable capsule endoscopy, colon capsule endoscopy, and others. Patient monitoring has been divided into capsule pH monitoring and others.
By target area, the global smart pills market is segmented into esophagus, small intestine, large intestine, and stomach.
On the basis of disease indication, the global smart pills market is segmented into esophageal diseases, small bowel diseases, colon diseases, and others.
By end use, the global smart pills market is segmented into hospitals, diagnostic centers, and research institutes.

Competitive Analysis:

Leading players in the global smart pills market include Intromedic, Pentax Medical, Medisafe, Jinshan Science Technology, BDD Limited, Check-Cap, RF Co. Ltd., Fujifilm Holdings Corporation, Medtronic, CapsoVision Inc., Proteus Digital Health Inc., and Olympus Corporation.

Regional Analysis:

The Americas are expected to dominate the global smart pills market over the forecast period due to the increasingly favorable reimbursement scenario and increasing government support. North America is the major regional market for smart pills, as technological development is rife in North America. The technology behind smart pills is quite complicated, requiring efforts from computing companies and healthcare industry players. This has made North America the epicenter of the smart pills market, as the presence of healthcare technology players is quite strong in the region. The high prevalence of chronic diseases in North America is also a significant factor in making this the largest regional segment of the global smart pills market.

In October 2019, eLucid announced plans to extend its smart pill monitoring services to smartwatches, allowing patients to receive reminders straight on their smartwatches. The service already includes app notifications, text messages, and phone calls.

Related Report-

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013